I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation - Wikidata - wikimedia - TriplyDB

I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation

I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation

http://www.wikidata.org/entity/Q24673242

about

Heterogeneous nuclear ribonucleoprotein P2 is an autoantibody target in mice deficient for Mer, Axl, and Tyro3 receptor tyrosine kinases Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells Annexin-II, DNA, and histones serve as factor H ligands on the surface of apoptotic cells Role of Natural Autoantibodies and Natural IgM Anti-Leucocyte Autoantibodies in Health and Disease Here, There, and Everywhere: The Ubiquitous Distribution of the Immunosignaling Molecule Lysophosphatidylcholine and Its Role on Chagas Disease SLE-associated risk factors affect DC function Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention Natural IgM: beneficial autoantibodies for the control of inflammatory and autoimmune disease Characterization of the human patatin-like phospholipase family The role of phospholipases A2 in schizophrenia Do not let death do us part: 'find-me' signals in communication between dying cells and the phagocytes.Clearing the dead: apoptotic cell sensing, recognition, engulfment, and digestion Sequence-specific binding of normal serum immunoglobulin M to exposed protein C-termini.The role of apoptosis proteins and complement components in the etiopathogenesis of systemic lupus erythematosus.Group VIA Ca2+-independent phospholipase A2 (iPLA2beta) and its role in beta-cell programmed cell death.Inhibitory effect of platinum and ruthenium bipyridyl complexes on porcine pancreatic phospholipase A2.Review: Soluble innate immune pattern-recognition proteins for clearing dying cells and cellular components: implications on exacerbating or resolving inflammation.Sca-1 influences the innate immune response during skeletal muscle regeneration.Phagocytosis of opsonized apoptotic cells: roles for 'old-fashioned' receptors for antibody and complement.Evaluation of the contribution of multiple DAMPs and DAMP receptors in cell death-induced sterile inflammatory responses.Lysophosphatidylcholine: A Novel Modulator of Trypanosoma cruzi Transmission IgM colocalises with complement and C reactive protein in infarcted human myocardium.IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells.Development and selection of marginal zone B cells.Circulating IgM Requires Plasma Membrane Disruption to Bind Apoptotic and Non-Apoptotic Nucleated Cells and Erythrocytes.Pathogenic natural antibodies propagate cerebral injury following ischemic stroke in mice.Autoreactivity in human IgG+ memory B cells.Manipulation of the glycan-specific natural antibody repertoire for immunotherapy Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals.FcγRIIb and BAFF differentially regulate peritoneal B1 cell survival.Calcium-independent phospholipases A2 and their roles in biological processes and diseases.IgM exacerbates glomerular disease progression in complement-induced glomerulopathy BLyS antagonists and peptide tolerance induction.Major Alterations of Phosphatidylcholine and Lysophosphotidylcholine Lipids in the Substantia Nigra Using an Early Stage Model of Parkinson's Disease.SLE, atherosclerosis and cardiovascular disease.Balancing diversity and tolerance: lessons from patients with systemic lupus erythematosus.Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory Defective B cell tolerance checkpoints in systemic lupus erythematosus The role of CR2 in autoimmunity.Complement deficiencies in humans and animals: links to autoimmunity.

P2860

Q24299348-3C62078E-DEA7-480B-BEB3-F0CF61D48FAD Q24322831-1D75CAE2-6C46-4CD6-B819-70A579E40CC7 Q24646683-C4F6DC49-BE4A-4D87-A0D8-AAC32023D49C Q26745015-85CBA728-5796-4660-8512-599721618FB5 Q26765838-04B126D2-D4BA-4DBF-95EC-A24EC3CDFDE0 Q26774797-5D698B52-A670-4A24-96BD-8A6E71581A14 Q26997377-9A1AB479-2C7E-43DD-AAAE-7E0819F5D3A7 Q27021242-3262263C-A3B2-4869-874E-C6D349EC8BC2 Q28248355-58C95C88-D07C-4BD3-BEC6-8A06D2724827 Q28305324-05FEFA95-5994-405A-AC92-6F21A28E26E5 Q30277318-AD24EA84-C098-4780-B62E-A2D5F8EACAB3 Q30408786-79F555DD-9636-43E9-8DE3-590706EB725A Q31061968-42EDAE27-506A-463E-9B22-524405CAB4D8 Q33754111-2358BDB2-C8D0-4F27-8FCC-1EFDB6F11798 Q33886495-75CD7D7B-79C3-451A-BB90-09D8E1395B61 Q34016733-1C81FB00-4D6D-4580-B40D-967DA180F008 Q34119510-FED336C0-2A89-4D7B-A707-1DFB1D8AF3D8 Q34597576-3A3CE284-6687-4C26-B2DF-1A8DC3D40802 Q34649313-E0C8F832-3C76-4A5E-9DDB-2C5E7E1A6B93 Q35225843-472CBD78-D4FF-44F8-AFA5-1B87175F1208 Q35503605-47E22059-F9A4-47DE-B35F-84618F26D902 Q35588500-A876D6A1-9DB8-4519-93A1-90B7783A759F Q35597401-3617C59F-168F-4737-B5C9-102AD2A48C5D Q35666707-1C0BC7B1-89C6-4A60-9261-2D4530BC3F69 Q35677438-2E33C935-5DE3-424B-A731-D21121F9DD5E Q35685695-E37D8D25-8918-4428-9BB0-BD519D78DBC6 Q35729131-22C6CAD6-4B88-4227-B791-FB9E4B99278A Q35920081-852B9DEB-33B5-4B02-B377-5D43C55A0049 Q35953495-75701D45-65B1-46E8-9216-FB813E51E474 Q35991862-5277A846-7BAB-4B16-82E4-8D921B5533F7 Q35994344-B649BFB0-3E1C-4002-B953-2C45116551F7 Q36016859-149A82FD-E0F7-4FC5-89E6-255C5163491F Q36088054-DA6114C4-ADC6-4102-A85B-94453D55F3ED Q36088639-0DBE6E58-0286-4C47-A3DA-E0DF344A3F4E Q36135534-FD7ED458-459A-4A02-8A13-F6B5D790B042 Q36215324-228814EA-B3FE-44D2-9492-6CDD6663CA56 Q36399652-DAFAA2F1-F989-4633-81C9-6119DA5CAC70 Q36402748-68D40C23-AC13-4602-A4EF-2E844ED8B1ED Q36572973-808B48DD-7011-41DB-9EB0-A24C1CAF00A2 Q36572977-18F0E0EB-DE99-40E2-A185-6EE282ECFC18

P2860

I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation

http://www.wikidata.org/entity/Q24673242

description

2002 nî lūn-bûn

@nan

2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

I-PLA(2) activation during apo ...... dies and complement activation

@ast

I-PLA(2) activation during apo ...... dies and complement activation

@en

I-PLA(2) activation during apo ...... dies and complement activation

@nl

type

label

I-PLA(2) activation during apo ...... dies and complement activation

@ast

I-PLA(2) activation during apo ...... dies and complement activation

@en

I-PLA(2) activation during apo ...... dies and complement activation

@nl

prefLabel

I-PLA(2) activation during apo ...... dies and complement activation

@ast

I-PLA(2) activation during apo ...... dies and complement activation

@en

I-PLA(2) activation during apo ...... dies and complement activation

@nl

P1433

Q24673242-43BFF353-CE3A-4D45-A06B-E68B666F6097

P1476

Q24673242-04D93B49-40E0-42E4-B4BF-7D67899582B4

P2093

Q24673242-1C1A07E1-5FE0-42FC-BFAB-FB9B04020AD5

Q24673242-37781890-F137-45B7-9901-D70B2DA4E5C5

Q24673242-493D1DD2-B277-45BC-A9F6-6C6BBA895CE5

Q24673242-694C144E-2191-433E-9068-65DBB012C0AB

Q24673242-828DD52C-A120-4365-909B-F0EF604EFBB8

P2860

Q24673242-02738C68-8967-4455-A1D7-2049D536DD39

Q24673242-058A47D0-7213-42F0-87AD-6AB1D4003921

Q24673242-080C72AD-58AD-41F1-9A3E-5FB31AF34CEB

Q24673242-0C74486B-6F86-4D26-94D1-093956C18601

Q24673242-0F204568-DE44-4B42-90ED-B3B28F072C26

Q24673242-15DD6D59-4342-484D-B020-5ECB0E0E8AD1

Q24673242-18F80A02-A780-471A-9056-A73925E608FC

Q24673242-19158E08-CFE4-4F15-A7A5-7E80A61212C0

Q24673242-1967D102-456E-4C74-9DB4-84AB28D9D533

Q24673242-20573395-DD07-4575-97D2-B3D7494B855C

P304

Q24673242-BB50F9D0-8598-4294-861E-1BEA84B2E1C0

P31

Q24673242-244647F0-20BB-4453-9936-9DCC964BA31E

P3181

Q24673242-0DC4C488-7C07-46C4-AE20-CB8FE06A34D5

P356

Q24673242-64A999B3-7735-4541-91A6-3FECB2CA7C6B

P407

Q24673242-49BA5D84-FD71-4ECF-BE0E-734C74D78247

P433

Q24673242-2A485A6A-9E13-4EAB-87CC-7AFB875B0403

P478

Q24673242-3F9D69B7-298B-4DEA-AF0E-019AA87DBCF9

P577

Q24673242-0E9C20FF-3E14-409D-B141-3BD4AFB89264

P5875

Q24673242-BC834526-8AC3-4393-92C4-446EBC154FF8

P698

Q24673242-60116C20-BA80-497A-9B29-B115FB5FF231

P921

Q24673242-5B65E612-18FB-41F5-9A23-39D702E1D079

Q24673242-A8E113C3-D3D6-46CC-B5CE-6D4D5FD6105B

P932

Q24673242-9CD1D23C-098D-4FA5-B368-DEA9A2432852

P3181

P356

P1433

Journal of Experimental Medicine

P1476

I-PLA(2) activation during apo ...... dies and complement activation

@en

P2093

Debra Gershov

http://www.w3.org/2001/XMLSchema#string

Keith B Elkon

http://www.w3.org/2001/XMLSchema#string

Nathan Brot

http://www.w3.org/2001/XMLSchema#string

Sun Jun Kim

http://www.w3.org/2001/XMLSchema#string

Xiaojing Ma

http://www.w3.org/2001/XMLSchema#string

P2860

C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells

The induction of tolerance by dendritic cells that have captured apoptotic cells

C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity

Dendritic cells and the control of immunity

Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity

Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response

IgG Fc receptors

Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF

Complement-dependent clearance of apoptotic cells by human macrophages.

Anti-phospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a beta 2-glycoprotein I-dependent manner.

P304

655-65

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1023894

http://www.w3.org/2001/XMLSchema#string

P356

10.1084/JEM.20020542

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

196

http://www.w3.org/2001/XMLSchema#string

P577

2002-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

246582713

http://www.w3.org/2001/XMLSchema#string

P698

12208880

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process

P932

2194002

http://www.w3.org/2001/XMLSchema#string